Ignite Creation Date:
2025-12-24 @ 4:06 PM
Ignite Modification Date:
2026-04-25 @ 3:08 PM
Study NCT ID:
NCT00748566
Status:
TERMINATED
Last Update Posted:
2021-03-03
First Post:
2008-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A1281173
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None